David Josephson MD FACS, Urology

Minimally Invasive Surgery, Surgical Oncology

Urologic Oncologist and Robotic Surgeon

8635 W 3rd StSte 1Los Angeles, CA 90048
Phone+1 310-854-9898
Fax+1 310-854-0627

Dr. Josephson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Josephson's full profile Already have an account?

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Urology, 2005
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Surgery, 1999 - 2001
Albert Einstein College of MedicineClass of 1999

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2001 - 2028
American Board of Urology Urology
National Board of Physicians and Surgeons Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Sage Intergy Meaningful Use Edition, Sage, 2011, 2016-2017
CMS Meaningful Use Stage 2 Certification Greenway Intergy Meaningful Use Edition, Greenway Health, LLC, 2011, 2016-2017
America's Top Doctors Castle Connolly, 2004-2014

Clinical Trials

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer Start of enrollment: 2022 Mar 01
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Contact

Publications & Presentations

PubMed

Prospective multicenter validation of a Urine-Based multiplex assay for risk stratification of patients presenting with gross hematuria.
Yair Lotan, Amit Gupta, Makito Miyake, Satoshi Anai, Michael Luu
Journal of the National Cancer Institute. 2026-08-17
An intra-patient contemporaneous comparison ofF-piflufolastat andF-flotufolastat urinary radioactivity and pelvic region detection rates in men with low PSA biochemica...
Luke T Nordquist, Jack R Andrews, Phillip H Kuo, Benjamin A Gartrell, David Josephson
European Journal of Nuclear Medicine and Molecular Imaging. 2026-05-01
7 citations
Investigating trends in interest for benign prostatic hyperplasia surgery options using Google Trends.
James P Daniels, Devin N Patel, Gloria Cecilia Galvan, Nadine A Friedrich, Sanjay Das
Prostate Cancer and Prostatic Diseases. 2024-03-01